Novartis Bioventures Ltd Eledon Pharmaceuticals, Inc. (ELDN) insider trading activity

Novartis Bioventures LTD is > 10% Shareholder of Eledon Pharmaceuticals, Inc.. Currently has a direct ownership of 4.49 Million shares of ELDN, which is worth approximately $19.3 Million. The most recent transaction as insider was on Jul 15, 2015, when has been sold 3,566 shares (Common Stock) at a price of $14.26 per share, resulting in proceeds of $50,851. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.49M

0% 3M change

0% 12M change

Total Value Held $19.3 Million

Novartis Bioventures Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2015	SELL Open market or private sale	$50,851 $14.26 p/Share	3,566 Reduced 0.08%	4,493,458 Common Stock
Jul 14 2015	SELL Open market or private sale	$401,477 $14.41 p/Share	27,861 Reduced 0.62%	4,497,024 Common Stock
Jul 13 2015	SELL Open market or private sale	$292,676 $14.2 p/Share	20,611 Reduced 0.45%	4,524,885 Common Stock
Jun 16 2015	SELL Open market or private sale	$15,982 $14.27 p/Share	1,120 Reduced 0.02%	4,545,496 Common Stock
Jun 12 2015	SELL Open market or private sale	$84,050 $14.2 p/Share	5,919 Reduced 0.13%	4,561,393 Common Stock
Jun 11 2015	SELL Open market or private sale	$395,825 $14.2 p/Share	27,875 Reduced 0.61%	4,567,312 Common Stock
Mar 19 2015	SELL Open market or private sale	$669,044 $14.5 p/Share	46,141 Reduced 0.99%	4,595,187 Common Stock
Mar 18 2015	SELL Open market or private sale	$43,500 $14.5 p/Share	3,000 Reduced 0.06%	4,641,328 Common Stock
Sep 22 2014	BUY Open market or private purchase	$4,875,000 $15.0 p/Share	325,000 Added 6.54%	4,644,328 Common Stock
Sep 22 2014	BUY Conversion of derivative security	-	4,319,328 Added 50.0%	4,319,328 Common Stock
Jun 15 2014	SELL Open market or private sale	$209,833 $14.2 p/Share	14,777 Reduced 0.32%	4,546,616 Common Stock

Also insider at

ATRX

Adhera Therapeutics, Inc. Healthcare

> 10% Shareholder

YMTX

YUMANITY THERAPEUTICS, INC. Healthcare

> 10% Shareholder

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

RARX

Ra Pharmaceuticals, Inc.

> 10% Shareholder

AADI

Aadi Bioscience, Inc. Healthcare

> 10% Shareholder

ALRN

AILERON THERAPEUTICS INC Healthcare

> 10% Shareholder

ALT

Altimmune, Inc. Healthcare

> 10% Shareholder

BCYC

BICYCLE THERAPEUTICS plc Healthcare

> 10% Shareholder

GRTX

Galera Therapeutics, Inc. Healthcare

AKUS

Akouos, Inc. Healthcare

NBL